| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Director
2 companies
Bentsur Ron serves as a Chairman &CEO at NVCT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 78 buys and 28 sells. Those positions are worth an estimated $82.7M at current prices.
Historically, Bentsur Ron's trades have earned a middling insider score of 64/100 across 73 rated trades. Over a 12-month horizon, 52.8% of those trades were profitable, with an average 12-month return of +6.6%.
The biggest single holding is NVCT (~$81.8M) as Chairman &CEO. Net of sales, the recent Form 4 record there shows accumulation of 392,965 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 350 | $14.61 | $5,112.15 | - | -40.9% | -55.9% | |
| Aug 11, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 300 | $14.73 | $4,418.40 | - | -46.2% | -55.7% | |
| Jul 21, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 335 | $14.92 | $4,997.85 | - | -39.6% | -55.3% | |
| Jul 19, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 200 | $14.33 | $2,866.00 | - | -34.2% | -55.0% | |
| Jul 14, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 260 | $15.52 | $4,035.40 | - | -36.1% | -56.0% | |
| Jul 6, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 320 | $14.88 | $4,761.60 | - | -27.5% | -59.3% | |
| Jun 26, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 750 | $16.50 | $12,375.00 | - | -16.6% | -56.8% | |
| Jun 21, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 500 | $17.88 | $8,940.00 | - | -19.7% | -61.5% | |
| Jun 8, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 350 | $17.45 | $6,107.90 | - | -19.4% | -63.8% | |
| May 31, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 330 | $17.28 | $5,702.40 | - | -17.0% | -63.4% |